Statement: Less than a quarter of participants in the primary trial had radiation dermatitis.
Primary_evidence: Adverse Events 1:   Total: 6/18 (33.33%)   Skin infection  [1]2/18 (11.11%)   Radiation dermatitis 2 [1]4/18 (22.22%) Adverse Events 2: